Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Melanoma 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Esophageal Neoplasms 2Carcinoma, Merkel Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Plasma Cell 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Kidney Neoplasms 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Filgrastim 3belinostat 2Gemcitabine 2Docetaxel 2Carboplatin 2tazemetostat 1resiquimod 1poly ICLC 1etoposide phosphate 1durvalumab 1Topotecan 1Thiotepa 1Thalidomide 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiosurgery 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Minocycline 1Immunotherapy 1Imatinib Mesylate 1Ifosfamide 1Heparin 1Gelclair 1Fluorouracil 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × poly ICLC × Genitourinary × Clear all
NCT00948961 2016-06-27

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Celldex Therapeutics

Phase 1/2 Completed
70 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡